FIELD: medicine.
SUBSTANCE: invention refers to medicine. What is presented is a peptide conjugate containong glycolised peptide bound covalently with a fragment of polyethylene glycol (PEG) through an intact glycosyl linking group.
EFFECT: invention provides preparing a new chemical compound containing a branched PEG molecule, a sialyl linking group and a low-antigenicity peptide.
3 cl, 7 dwg, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GLYCO-PEG GRANULOCYTE COLONY-STIMULATING FACTOR | 2004 |
|
RU2400490C2 |
| METHOD FOR PRODUCING PHYSIOLOGICALLY ACTIVE POLYPEPTIDE COMPLEX | 2012 |
|
RU2624129C2 |
| CYTOKINE CONJUGATES FOR TREATMENT OF AUTOIMMUNE DISEASES | 2018 |
|
RU2787201C2 |
| PROTEIN COMPLEX, OBTAINED BY USING FRAGMENT OF IMMUNOGLOBULIN, AND METHOD OF SUCH COMPLEX OBTAINING | 2004 |
|
RU2356909C2 |
| INSULINOTROPIC COMPLEX IN WHICH IMMUNOGLOBULIN FRAGMENT IS USED | 2008 |
|
RU2436589C2 |
| GLYCOPOLYSIALYLATION OF PROTEINS, WHICH ARE NOT BLOOD CLOTTING PROTEINS | 2010 |
|
RU2533619C2 |
| CYTOKINE CONJUGATES FOR TREATMENT OF PROLIFERATIVE AND INFECTIOUS DISEASES | 2018 |
|
RU2786116C2 |
| GLYCOPOLYSIALYLATION OF PROTEINS THAT ARE NOT THE PROTEINS OF THE BLOOD CLOTTING | 2014 |
|
RU2662807C2 |
| PEGYLATED RECOMBINANT CONSENSUS INTERFERON VERSION CONJUGATE AND PREPARATION METHOD AND USE THEREOF | 2011 |
|
RU2575796C9 |
| HAEMOGLOBIN COMPOSITION | 2010 |
|
RU2589254C2 |
